RN7SL39P

Across TCGA pan-cancer cohorts, RN7SL39P RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of RN7SL39P’s most consistent transcriptional readouts.

The strongest signal is observed in cholangiocarcinoma (CHOL), where RN7SL39P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RN7SL39P is over-expressed in tumor.

CHOL are the cancer types where RN7SL39P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL39P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
CHOL	Female	All	+0.370	.003	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

RN7SL39P–CHOL

Open the CHOL breakdown →